Thanks SF. In my research it is becoming clear that the MM products for epilepsy are not a one size fits all on both counts. That is the mm products are unique formulations which work on specific epilepsy conditions. GW product was targeting two very rare forms yet gets promoted as epilepsy drug as if it deals with all forms. Tilrays while it seems to be a small test samples sounds as if it is for a broader range so could well be direct competition...
- Forums
- ASX - By Stock
- Cannepil
Thanks SF. In my research it is becoming clear that the MM...
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.035(12.1%) |
Mkt cap ! $13.83M |
Open | High | Low | Value | Volume |
25.5¢ | 25.5¢ | 25.5¢ | $465 | 1.824K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4408 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 8264 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4408 | 0.250 |
1 | 2200 | 0.230 |
1 | 14900 | 0.220 |
1 | 16950 | 0.200 |
1 | 5588 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 8264 | 3 |
0.300 | 136 | 2 |
0.305 | 2073 | 2 |
0.310 | 50 | 1 |
0.320 | 50 | 1 |
Last trade - 12.38pm 11/11/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online